Hillsdale Investment Management Inc. Durect Corp Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$1.65 - $2.43 $611,655 - $900,801	-370,700 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.6 - $2.35 $39,840 - $58,515	24,900 Added 7.2%	370,700 $634,000
Q2 2020 Aug 11, 2020	BUY	$1.33 - $2.76 $3,990 - $8,280	3,000 Added 0.88%	345,800 $802,000
Q4 2019 Feb 12, 2020	BUY	$1.69 - $3.8 $579,332 - $1.3 Million	342,800 New	342,800 $1.3 Million

559K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $298M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.